DK0656014T3 - Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition - Google Patents

Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition

Info

Publication number
DK0656014T3
DK0656014T3 DK94911348T DK94911348T DK0656014T3 DK 0656014 T3 DK0656014 T3 DK 0656014T3 DK 94911348 T DK94911348 T DK 94911348T DK 94911348 T DK94911348 T DK 94911348T DK 0656014 T3 DK0656014 T3 DK 0656014T3
Authority
DK
Denmark
Prior art keywords
protein
pharmaceutical composition
many group
reagent kit
immunity
Prior art date
Application number
DK94911348T
Other languages
English (en)
Inventor
Gunnar Lindahl
Margareth Stalhammar-Carlemalm
Lars Stenberg
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Application granted granted Critical
Publication of DK0656014T3 publication Critical patent/DK0656014T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94911348T 1993-03-19 1994-03-21 Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition DK0656014T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19
PCT/SE1994/000246 WO1994021685A1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK0656014T3 true DK0656014T3 (da) 2003-08-11

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94911348T DK0656014T3 (da) 1993-03-19 1994-03-21 Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition

Country Status (17)

Country Link
US (1) US5869064A (da)
EP (1) EP0656014B1 (da)
JP (1) JP3976334B2 (da)
KR (1) KR100331358B1 (da)
CN (1) CN1046291C (da)
AT (1) ATE240351T1 (da)
CA (1) CA2158658A1 (da)
DE (1) DE69432658T2 (da)
DK (1) DK0656014T3 (da)
ES (1) ES2194024T3 (da)
HU (1) HU217582B (da)
NZ (1) NZ263275A (da)
PT (1) PT656014E (da)
SG (1) SG47049A1 (da)
SI (1) SI0656014T1 (da)
WO (1) WO1994021685A1 (da)
ZA (1) ZA941958B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
CA2321106C (en) 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
CN101066447A (zh) * 1998-12-22 2007-11-07 微科学有限公司 基因和蛋白质,及它们的用途
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
CA2354843A1 (en) 1998-12-22 2000-06-29 Microscience Limited Outer surface proteins, their genes, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
KR100802198B1 (ko) * 1998-12-23 2008-02-11 샤이어 바이오켐 인코포레이티드 신규한 스트렙토코커스 항원
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
WO2002099133A1 (fr) * 2001-05-31 2002-12-12 Fuso Pharmaceutical Industries, Ltd. Procede ameliore de detection et d'identification de micro-organismes causes d'infections
JPWO2002101037A1 (ja) * 2001-05-31 2005-04-07 扶桑薬品工業株式会社 食細胞機能の評価方法およびその利用
ES2381967T3 (es) * 2002-02-11 2012-06-04 Id Biomedical Corporation Antígeno de streptococcus del grupo B
EP1845944A4 (en) * 2005-02-08 2011-07-27 Id Biomedical Corp Of Quebec C O B As Glaxosmithkline Biolog North America PHARMACEUTICAL COMPOSITIONS
SI2144924T1 (sl) * 2007-04-16 2016-12-30 Minervax Aps Cepivo s fuzijskimi beljakovinami
CN108135992A (zh) 2015-10-21 2018-06-08 米纳瓦克斯有限责任公司 免疫原性融合蛋白
US10888610B2 (en) 2015-12-30 2021-01-12 Minerv Ax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
EP3638301A1 (en) 2017-06-16 2020-04-22 GlaxoSmithKline Biologicals S.A. Method of treatment
US12533418B2 (en) 2019-11-22 2026-01-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (en) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
JPH06506114A (ja) * 1991-03-29 1994-07-14 ファウルマン，　エルビン 新規な遺伝子及びＩｇＡ結合蛋白質の製造方法

Also Published As

Publication number Publication date
US5869064A (en) 1999-02-09
JPH09500092A (ja) 1997-01-07
JP3976334B2 (ja) 2007-09-19
CA2158658A1 (en) 1994-09-29
KR960701096A (ko) 1996-02-24
ES2194024T3 (es) 2003-11-16
KR100331358B1 (ko) 2002-08-13
SG47049A1 (en) 1998-03-20
WO1994021685A1 (en) 1994-09-29
EP0656014A1 (en) 1995-06-07
AU6389194A (en) 1994-10-11
EP0656014B1 (en) 2003-05-14
PT656014E (pt) 2003-09-30
CN1119442A (zh) 1996-03-27
HU9501993D0 (en) 1995-08-28
DE69432658T2 (de) 2004-04-08
HUT72841A (en) 1996-05-28
ATE240351T1 (de) 2003-05-15
SI0656014T1 (en) 2003-12-31
AU681130B2 (en) 1997-08-21
HK1008825A1 (en) 1999-05-21
NZ263275A (en) 1997-07-27
ZA941958B (en) 1995-01-27
DE69432658D1 (de) 2003-06-18
CN1046291C (zh) 1999-11-10
HU217582B (hu) 2000-02-28

Similar Documents

Publication Publication Date Title
DK0656014T3 (da) Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition
DK1203817T3 (da) Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose
DE69735715D1 (de) Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
CA2123579A1 (en) Recombinant multivalent m protein vaccine
PT726955E (pt) Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes
FI962247A7 (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden kä yttömenetelmät
EP1589109A3 (en) VMP-like sequences of pathogenic borrelia
EP1985705A3 (en) Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
NO944245D0 (no) Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
BR9812791A (pt) Sequências de ácido nucléico associadas à virulência e seu uso
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
SE9804491D0 (sv) Novel fibronectin-binding protein
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
DK381787A (da) Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis
DE60031106D1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme
WO2002079475A3 (en) Streptococcus pyogenes antigens and corresponding dna fragments